Published in Gene Therapy Weekly, October 20th, 2005
Study 1: Continued delivery of glial cell line-derived neurotrophic factor (GDNF) may optimize neural transplantation therapy, report researchers at Wallenberg Neuroscience Center.
Y.H. Ahn and associates reported, "We investigated whether a continuous supply of GDNF via encapsulated genetically modified cells can promote survival and fiber outgrowth from xenotransplanted human dopaminergic neurons."
The scientists explained, "Cells genetically engineered to continuously secrete GDNF were confined in hollow fiber-based macrocapsules. Each...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-10-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.